Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.38 |
| ▸ | APP | P05067 | 2/20 | 0.34 |
| ▸ | TPMT | P51580 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | METAP2 | P50579 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL586534 | 0.83 | NR1H2 (0.50) | NR1H2NR1H3 | |
| SCHEMBL9968169 | 0.81 | ESR1 (0.44) | NR1H2NR1H3HDAC8APPTPMT | |
| SCHEMBL10032994 | 0.80 | NR1H2 (0.42) | NR1H2NR1H3APP | |
| SCHEMBL21549228 | 0.75 | SCN5A (0.35) | NR1H2NR1H3 | |
| SCHEMBL10997473 | 0.73 | NR1H2 (0.44) | NR1H2NR1H3 | |
| SCHEMBL2703720 | 0.73 | HDAC8 (0.42) | HDAC8APPTPMTCA1CA2 | |
| SCHEMBL6434075 | 0.73 | APP (0.32) | HDAC8APP | |
| SCHEMBL19257007 | 0.73 | NR1H2 (0.50) | NR1H2NR1H3HDAC8APP | |
| SCHEMBL987122 | 0.71 | ACHE (0.53) | NR1H2NR1H3CA1CA2 | |
| SCHEMBL716493 | 0.71 | PYCR1 (0.34) | HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111499566-A | Pyridine derivative compound and preparation method thereof | 南京工业大学 | 2020-08-07 | — | — | CN | claimed |
| EP-4306612-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | Samsung Electronics Co., Ltd. (KR) | 2024-01-17 | — | — | EP | disclosed |
| US-20230371357-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-16 | — | — | US | disclosed |
| US-11718606-B2 | Polycyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2023-08-08 | — | — | US | disclosed |
| US-20220298185-A1 | Nucleoside Prodrugs and Uses Related Thereto | UNIV EMORY (US) | 2022-09-22 | — | — | US | disclosed |
| EP-3564249-B1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG CHEMICAL LTD (KR) | 2021-01-20 | — | — | EP | disclosed |
| US-10862164-B2 | Polymer electrolyte, method of preparing the polymer electrolyte, and lithium metal battery including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-12-08 | — | — | US | disclosed |
| CN-111499566-A | Pyridine derivative compound and preparation method thereof | 南京工业大学 | 2020-08-07 | — | — | CN | disclosed |
| US-10604469-B2 | Method for the preparation of a partially hydrogenated polyacene and an intermediate thereof | FUNDACIO INSTITUT CATALA D'INVESTIGACIO QUIMICA (ES) | 2020-03-31 | — | — | US | disclosed |
| US-20200048232-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-13 | — | — | US | disclosed |
| US-20160020400-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2016-01-21 | — | — | US | disclosed |
| US-20120177578-A1 | COMPOSITIONS, METHODS, AND SYSTEMS COMPRISING FLUOROUS-SOLUBLE POLYMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-07-12 | — | — | US | disclosed |
| WO-2010007756-A1 | PYRIDINE DERIVATIVE HAVING TTK INHIBITION ACTIVITY | 塩野義製薬株式会社 (JP) | 2010-01-21 | — | — | WO | disclosed |
| US-20090256468-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-15 | — | — | US | disclosed |
| EP-2096108-A1 | Novel organic electroluminescent compounds and organic electroluminscent device using the same | Gracel Display Inc. (KR) | 2009-09-02 | — | — | EP | disclosed |
| US-20090200926-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-08-13 | — | — | US | disclosed |
| EP-2067767-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-06-10 | — | — | EP | disclosed |
| US-20050101063-A1 | Three-terminal field-controlled molecular devices | TOUR JAMES M (US) | 2005-05-12 | — | — | US | disclosed |
| WO-2002035580-A2 | THREE-TERMINAL FIELD-CONTROLLED MOLECULAR DEVICES | MOLECULAR ELECTRONICS CORPORATION (US) | 2002-05-02 | — | — | WO | disclosed |
| US-6123917-A | Method for making cocaine receptor binding ligands and intermediates therefor | RESEARCH TRIANGLE INSTITUTE (US) | 2000-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220298185-A1 | Nucleoside Prodrugs and Uses Related Thereto | PNPO, GSTO1, CYP2C18 | NR1H2 504/4885NR1H3 369/4885HDAC8 1237/4885 |
| US-20200048232-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, CYP1A1 | NR1H2 103/4885NR1H3 80/4885HDAC8 4376/4885 |
| US-11718606-B2 | Polycyclic compound and organic light emitting element comprising same | CRY1, CRY2, CYP1A1 | NR1H2 103/4885NR1H3 80/4885HDAC8 4376/4885 |
| US-10604469-B2 | Method for the preparation of a partially hydrogenated polyacene and an intermediate thereof | PARN, PCBP1, PARG | NR1H2 2883/4885NR1H3 2599/4885HDAC8 1415/4885 |
| US-20230371357-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | L1CAM, CHRM1, FOXM1 | NR1H2 1579/4885NR1H3 1819/4885HDAC8 4643/4885 |
| US-20090256468-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ORMDL3, OCIAD1, OCIAD2 | NR1H2 272/4885NR1H3 339/4885HDAC8 4579/4885 |
| US-20090200926-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | NQO1, NDUFS2, NDUFS5 | NR1H2 1830/4885NR1H3 1889/4885HDAC8 4645/4885 |
| US-20120177578-A1 | COMPOSITIONS, METHODS, AND SYSTEMS COMPRISING FLUOROUS-SOLUBLE POLYMERS | NAF1, PFAS, MALT1 | NR1H2 690/4885NR1H3 403/4885HDAC8 4692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.